Alprazolam (Romanian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Alprazolam" in Romanian language version.

refsWebsite

Global rank Romanian rank

74nih.gov

4^th place

65doi.org

2^nd place

3^rd place

19web.archive.org

1^st place

6books.google.com

3^rd place

6^th place

5drugs.com

399^th place

157^th place

4anm.ro

low place

352^nd place

3researchgate.net

120^th place

137^th place

3patents.google.com

1,182^nd place

2,315^th place

3fda.gov

447^th place

173^rd place

2drugbank.com

low place

160^th place

2ebi.ac.uk

5,849^th place

138^th place

2rxlist.com

7,927^th place

5,692^nd place

2medicinenet.com

3,840^th place

5,508^th place

2umich.edu

459^th place

512^th place

2handle.net

102^nd place

537^th place

2psu.edu

207^th place

281^st place

2justice.gov

918^th place

5,856^th place

2psychiatrist.com

low place

2benzo.org.uk

low place

2worldcat.org

5^th place

11^th place

2acs.org

1,248^th place

789^th place

1cas.org

8,332^nd place

310^th place

1chemspider.com

8,573^rd place

247^th place

1just.ro

low place

90^th place

1therecoveryvillage.com

low place

1psychiatryonline.org

4,032^nd place

6,156^th place

1barglow.com

low place

1drugbank.ca

4,294^th place

450^th place

1google.ca

838^th place

285^th place

1ingentaconnect.com

3,306^th place

1,460^th place

1forbes.com

54^th place

143^rd place

1clincalc.com

3,912^th place

6,145^th place

1vu.nl

8,540^th place

low place

1netdoctor.co.uk

9,484^th place

6,907^th place

1archive.is

87^th place

68^th place

1bnf.org

low place

1mayoclinic.org

1,610^th place

2,809^th place

1escholarship.org

1,523^rd place

1,500^th place

1e-lactancia.org

low place

1drugabuse.com

low place

1medworksmedia.com

low place

1annals.org

low place

8,976^th place

1thedrugclassroom.com

low place

1rxwiki.com

low place

1wiley.com

222^nd place

251^st place

1cnn.com

28^th place

85^th place

1merriam-webster.com

209^th place

206^th place

1non-benzodiazepines.org.uk

low place

1nytimes.com

7^th place

25^th place

1samhsa.gov

low place

1rhrn.ro

low place

3,782^nd place

1state.oh.us

5,859^th place

9,480^th place

1ualberta.ca

3,600^th place

9,927^th place

1axisresidentialtreatment.com

low place

1alprazolamaddictionhelp.com

low place

1empr.com

low place

1cnas.ro

low place

5,786^th place

1usdoj.gov

2,755^th place

8,634^th place

1statutelaw.gov.uk

low place

9,694^th place

1gesetze-im-internet.de

1,249^th place

4,545^th place

1incb.org

low place

2,122^nd place

1lege5.ro

low place

57^th place

acs.org

pubs.acs.org

Hester JB, Rudzik AD, Kamdar BV (1971). „6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines which have central nervous system depressant activity”. Journal of Medicinal Chemistry. 14 (11): 1078–1081. doi:10.1021/jm00293a015.

acs.org

„Alprazolam - American Chemical Society”. American Chemical Society. 3 noiembrie 2014. Accesat în 21 februarie 2020.

alprazolamaddictionhelp.com

„Street Names for Alprazolam”. Alprazolamaddictionhelp.com. Arhivat din original la 22 februarie 2014. Accesat în 14 februarie 2014.

anm.ro

„Rezumatul caracteristicilor produsului - Xanax comprimate (0,25 mg, 0,5 mg, 1 mg, 2 mg)” (PDF). Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România. Accesat în 20 februarie 2020.
„Rezumatul caracteristicilor produsului - Frontin 1 mg comprimate” (PDF). Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România. Arhivat din original (PDF) la 21 februarie 2020. Accesat în februarie 2020.
„Nomenclatorul medicamentelor pentru uz uman - Alprazolamum”, Agenția Națională a Medicamentului și a Dispozitivelor Medicale, accesat în 21 februarie 2020
„Rezumatul caracteristicilor produsului - Alprazolam Atb 0,25 mg comprimate” (PDF). Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România. Accesat în 21 februarie 2020.

annals.org

Almeida JC, Grimsley EW (1996). „Coma from the health food store: interaction between kava and alprazolam”. Annals of Internal Medicine. 125 (11): 940–1. doi:10.7326/0003-4819-125-11-199612010-00023. PMID 8967683.

archive.is

„Alprazolam”. British National Formulary. 2007. Arhivat din original la 20 iulie 2012. Accesat în 3 august 2007.

axisresidentialtreatment.com

„Street Terms for Xanax”. Axisresidentialtreatment.com. Arhivat din original la 22 februarie 2014. Accesat în 14 februarie 2014.

barglow.com

Moylan S, Giorlando F, Nordfjærn T, Berk M (martie 2012). „The role of alprazolam for the treatment of panic disorder in Australia” (PDF). The Australian and New Zealand Journal of Psychiatry. 46 (3): 212–24. doi:10.1177/0004867411432074. PMID 22391278.

benzo.org.uk

Ashton, Heather (august 2002). „The Ashton Manual – Benzodiazepines: How They Work and How to Withdraw”. Benzo.org.uk. Accesat în 31 octombrie 2008.
Fyer AJ, Liebowitz MR, Gorman JM, Campeas R, Levin A, Davies SO, Goetz D, Klein DF (martie 1987). „Discontinuation of alprazolam treatment in panic patients”. The American Journal of Psychiatry. 144 (3): 303–8. doi:10.1176/ajp.144.3.303. PMID 3826428.

bnf.org

„Alprazolam”. British National Formulary. 2007. Arhivat din original la 20 iulie 2012. Accesat în 3 august 2007.

books.google.com

Goldberg, Raymond (2009). Drugs Across the Spectrum (în engleză). Cengage Learning. p. 195. ISBN 9781111782009.
Pavuluri MN, Janicak PG, Marder SR (2010). Principles and Practice of Psychopharmacotherapy (ed. 5th). Philadelphia, PA: Wolters Kluwer Health/ Lippincott Williams & Wilkins. p. 535. ISBN 978-1-60547-565-3.
Schatzberg A, DeBattista C (2003). Manual of Clinical Psychopharmacology. Washington, DC: American Psychiatric Pub. p. 391. ISBN 978-1-58562-209-2. Accesat în 22 ianuarie 2014.
Galanter M (2008). The American Psychiatric Publishing Textbook of Substance Abuse Treatment (ed. 4th). American Psychiatric Publishing. p. 222. ISBN 978-1-58562-276-4. Accesat în 22 ianuarie 2014.
Mesibov, Ginnie (2004). Outer Strength, Inner Strength. Xulon Press. p. 213. ISBN 9781594675041. Some people sell Xanax on the street for ten or fifteen dollars a pill. They call them Xannies.
Curry, Mark (2009). Dancing with the Devil: How Puff Burned the Bad Boys of Hip-hop. NewMark Books. p. 120. ISBN 9780615276502.

cas.org

commonchemistry.cas.org

CAS Common Chemistry, accesat în 10 aprilie 2021

chemspider.com

Alprazolam (în engleză), ChemSpider, accesat în 19 noiembrie 2016

clincalc.com

„The Top 300 of 2019”. clincalc.com. Accesat în 22 decembrie 2018.

cnas.ro

„Regimul juridic al plantelor, substanțelor și preparatelor stupefiante și psihotrope”. Casa Județeană de Asigurări de Sănătate Maramureș. Arhivat din original la 21 februarie 2020. Accesat în 21 februarie 2020.

cnn.com

money.cnn.com

Staff, CNN/Money. It's official: Pfizer buys Pharmacia. 16 aprilie 2003; accesat pe 21 februarie 2020

doi.org

Work Group on Panic Disorder (ianuarie 2009). APA Practice Guideline for the Treatment of Patients With Panic Disorder (PDF). 1 (ed. 2nd). doi:10.1176/appi.books.9780890423905.154688. ISBN 978-0-89042-385-1.
Moylan S, Giorlando F, Nordfjærn T, Berk M (martie 2012). „The role of alprazolam for the treatment of panic disorder in Australia” (PDF). The Australian and New Zealand Journal of Psychiatry. 46 (3): 212–24. doi:10.1177/0004867411432074. PMID 22391278.
Dodds TJ (martie 2017). „Prescribed Benzodiazepines and Suicide Risk: A Review of the Literature”. The Primary Care Companion for CNS Disorders. 19 (2). doi:10.4088/PCC.16r02037. PMID 28257172.
Verster JC, Volkerts ER (2004). „Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature”. CNS Drug Reviews. 10 (1): 45–76. doi:10.1111/j.1527-3458.2004.tb00003.x. PMC 6741717 . PMID 14978513.
Mandrioli, R.; Mercolini, L.; Raggi, M. A. (2008). „Benzodiazepine Metabolism: An Analytical Perspective”. Current Drug Metabolism. 9 (8): 827–844. doi:10.2174/138920008786049258. PMID 18855614.
Wick JY (2013). „The History of Benzodiazepines”. The Consultant Pharmacist. 28 (9): 538–548. doi:10.4140/tcp.n.2013.538.
Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ (octombrie 2002). „World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders”. The World Journal of Biological Psychiatry. 3 (4): 171–99. doi:10.3109/15622970209150621. PMID 12516310.
van Marwijk H, Allick G, Wegman F, Bax A, Riphagen II (iulie 2012). van Marwijk, Harm, ed. „Alprazolam for depression” (PDF). The Cochrane Database of Systematic Reviews. 7 (7): CD007139. doi:10.1002/14651858.CD007139.pub2. PMC 6769182 . PMID 22786504. Arhivat din original (PDF) la 11 august 2017. Accesat în 20 februarie 2020.
Lydiard RB, Laraia MT, Ballenger JC, Howell EF (mai 1987). „Emergence of depressive symptoms in patients receiving alprazolam for panic disorder”. The American Journal of Psychiatry. 144 (5): 664–5. doi:10.1176/ajp.144.5.664. PMID 3578580.
Williams D, McBride AJ (1998). „The drug treatment of alcohol withdrawal symptoms: a systematic review”. Alcohol & Alcoholism. 33 (2): 103–115. doi:10.1093/oxfordjournals.alcalc.a008365. PMID 9566471.
Tsavaris N, Tsoutsos H, Bacoyannis C, Mylonakis N, Karvounis N, Kozatsani-Halividi D, Tsaroucha-Noutsou E, Klinaki A, Kosmidis P (1991). „Antiemetic efficacy of alprazolam in carboplatin-induced emesis”. Chemotherapy. 37 (5): 364–70. doi:10.1159/000238880. PMID 1804597.
Authier N, Balayssac D, Sautereau M, Zangarelli A, Courty P, Somogyi AA, Vennat B, Llorca PM, Eschalier A (noiembrie 2009). „Benzodiazepine dependence: focus on withdrawal syndrome”. Annales Pharmaceutiques Francaises. 67 (6): 408–13. doi:10.1016/j.pharma.2009.07.001. PMID 19900604.
Hori A (februarie 1998). „Pharmacotherapy for personality disorders”. Psychiatry and Clinical Neurosciences. 52 (1): 13–9. doi:10.1111/j.1440-1819.1998.tb00967.x. PMID 9682928.
Gardner DL, Cowdry RW (ianuarie 1985). „Alprazolam-induced dyscontrol in borderline personality disorder”. The American Journal of Psychiatry. 142 (1): 98–100. doi:10.1176/ajp.142.1.98. PMID 2857071.
Kozená L, Frantik E, Horváth M (mai 1995). „Vigilance impairment after a single dose of benzodiazepines”. Psychopharmacology. 119 (1): 39–45. doi:10.1007/BF02246052. PMID 7675948.
Cassano GB, Toni C, Petracca A, Deltito J, Benkert O, Curtis G, Hippius H, Maier W, Shera D, Klerman G (martie 1994). „Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo” (PDF). European Neuropsychopharmacology. 4 (1): 47–53. doi:10.1016/0924-977X(94)90314-X. hdl:2027.42/31721. PMID 8204996.
Elie R, Lamontagne Y (iunie 1984). „Alprazolam and diazepam in the treatment of generalized anxiety”. Journal of Clinical Psychopharmacology. 4 (3): 125–9. doi:10.1097/00004714-198406000-00002. PMID 6145726.
Noyes R, DuPont RL, Pecknold JC, Rifkin A, Rubin RT, Swinson RP, Ballenger JC, Burrows GD (mai 1988). „Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety”. Archives of General Psychiatry. 45 (5): 423–8. doi:10.1001/archpsyc.1988.01800290037005. PMID 3358644.
Kripke DF (februarie 2016). „Mortality Risk of Hypnotics: Strengths and Limits of Evidence” (PDF). Drug Safety. 39 (2): 93–107. doi:10.1007/s40264-015-0362-0. PMID 26563222.
Patorno E, Glynn RJ, Levin R, Lee MP, Huybrechts KF (2017). „Benzodiazepines and risk of all cause mortality in adults: cohort study”. BMJ (în engleză). 358 (j2941). doi:10.1136/bmj.j2941. PMC 5499256 . PMID 28684397.
Rapaport M, Braff DL (ianuarie 1985). „Alprazolam and hostility”. The American Journal of Psychiatry. 142 (1): 146a–146. doi:10.1176/ajp.142.1.146a. PMID 2857070.
Arana GW, Pearlman C, Shader RI (martie 1985). „Alprazolam-induced mania: two clinical cases”. The American Journal of Psychiatry. 142 (3): 368–9. doi:10.1176/ajp.142.3.368. PMID 2857534.
Strahan A, Rosenthal J, Kaswan M, Winston A (iulie 1985). „Three case reports of acute paroxysmal excitement associated with alprazolam treatment”. The American Journal of Psychiatry. 142 (7): 859–61. CiteSeerX 10.1.1.461.6316 . doi:10.1176/ajp.142.7.859. PMID 2861755.
Reddy J, Khanna S, Anand U, Banerjee A (august 1996). „Alprazolam-induced hypomania”. The Australian and New Zealand Journal of Psychiatry. 30 (4): 550–2. CiteSeerX 10.1.1.941.5119 . doi:10.3109/00048679609065031. PMID 8887708.
Béchir M, Schwegler K, Chenevard R, Binggeli C, Caduff C, Büchi S, Buddeberg C, Lüscher TF, Noll G (iulie 2007). „Anxiolytic therapy with alprazolam increases muscle sympathetic activity in patients with panic disorders”. Autonomic Neuroscience. 134 (1–2): 69–73. doi:10.1016/j.autneu.2007.01.007. PMID 17363337.
Oo CY, Kuhn RJ, Desai N, Wright CE, McNamara PJ (septembrie 1995). „Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk”. British Journal of Clinical Pharmacology. 40 (3): 231–6. doi:10.1111/j.1365-2125.1995.tb05778.x. PMC 1365102 . PMID 8527284.
Iqbal MM, Sobhan T, Ryals T (ianuarie 2002). „Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant” (PDF). Psychiatric Services. 53 (1): 39–49. doi:10.1176/appi.ps.53.1.39. PMID 11773648.
García-Algar O, López-Vílchez MA, Martín I, Mur A, Pellegrini M, Pacifici R, Rossi S, Pichini S (2007). „Confirmation of gestational exposure to alprazolam by analysis of biological matrices in a newborn with neonatal sepsis”. Clinical Toxicology. 45 (3): 295–8. doi:10.1080/15563650601072191. PMID 17453885.
Isbister GK, O'Regan L, Sibbritt D, Whyte IM (iulie 2004). „Alprazolam is relatively more toxic than other benzodiazepines in overdose”. British Journal of Clinical Pharmacology. 58 (1): 88–95. doi:10.1111/j.1365-2125.2004.02089.x. PMC 1884537 . PMID 15206998.
An H, Godwin J (decembrie 2016). „Flumazenil in benzodiazepine overdose”. British Journal of Clinical Pharmacology. 188 (17-18): E537. doi:10.1503/cmaj.160357. PMC 5135539 . PMID 27920113.
Juergens SM, Morse RM (mai 1988). „Alprazolam dependence in seven patients”. The American Journal of Psychiatry. 145 (5): 625–7. doi:10.1176/ajp.145.5.625. PMID 3258735.
Closser MH, Brower KJ (1994). „Treatment of alprazolam withdrawal with chlordiazepoxide substitution and taper” (PDF). Journal of Substance Abuse Treatment. 11 (4): 319–23. doi:10.1016/0740-5472(94)90042-6. hdl:2027.42/31476. PMID 7966502.
Fyer AJ, Liebowitz MR, Gorman JM, Campeas R, Levin A, Davies SO, Goetz D, Klein DF (martie 1987). „Discontinuation of alprazolam treatment in panic patients”. The American Journal of Psychiatry. 144 (3): 303–8. doi:10.1176/ajp.144.3.303. PMID 3826428.
Breier A, Charney DS, Nelson JC (decembrie 1984). „Seizures induced by abrupt discontinuation of alprazolam”. The American Journal of Psychiatry. 141 (12): 1606–7. doi:10.1176/ajp.141.12.1606. PMID 6150649.
Noyes R, Perry PJ, Crowe RR, Coryell WH, Clancy J, Yamada T, Gabel J (ianuarie 1986). „Seizures following the withdrawal of alprazolam”. The Journal of Nervous and Mental Disease. 174 (1): 50–2. doi:10.1097/00005053-198601000-00009. PMID 2867122.
Wolf B, Griffiths RR (decembrie 1991). „Physical dependence on benzodiazepines: differences within the class”. Drug and Alcohol Dependence. 29 (2): 153–6. doi:10.1016/0376-8716(91)90044-Y. PMID 1686752.
Higgitt A, Fonagy P, Lader M (1988). „The natural history of tolerance to the benzodiazepines”. Psychological Medicine. Monograph Supplement. 13: 1–55. doi:10.1017/S0264180100000412. PMID 2908516.
Greenblatt DJ, von Moltke LL, Harmatz JS, Durol AL, Daily JP, Graf JA, Mertzanis P, Hoffman JL, Shader RI (aprilie 2000). „Alprazolam-ritonavir interaction: implications for product labeling”. Clin Pharmacol Ther. 67 (4): 335–41. doi:10.1067/mcp.2000.105757. PMID 10801241.
Dresser GK, Spence JD, Bailey DG (ianuarie 2000). „Pharmacokinetic-pharmacodymic consequences and clinical relevance of cytochrome P450 3A4 inhibition”. Clinical Pharmacokinetics. 38 (1): 41–57. doi:10.2165/00003088-200038010-00003. PMID 10668858.
Greenblatt DJ, Wright CE (iunie 1993). „Clinical pharmacokinetics of alprazolam. Therapeutic implications”. Clinical Pharmacokinetics. 24 (6): 453–71. doi:10.2165/00003088-199324060-00003. PMID 8513649.
Wang JS, DeVane CL (2003). „Pharmacokinetics and drug interactions of the sedative hypnotics” (PDF). Psychopharmacology Bulletin. 37 (1): 10–29. doi:10.1007/BF01990373. PMID 14561946. Arhivat din original (PDF) la 9 iulie 2007.
Back DJ, Orme ML (iunie 1990). „Pharmacokinetic drug interactions with oral contraceptives”. Clinical Pharmacokinetics. 18 (6): 472–84. doi:10.2165/00003088-199018060-00004. PMID 2191822.
Almeida JC, Grimsley EW (1996). „Coma from the health food store: interaction between kava and alprazolam”. Annals of Internal Medicine. 125 (11): 940–1. doi:10.7326/0003-4819-125-11-199612010-00023. PMID 8967683.
Izzo AA, Ernst E (2001). „Interactions between herbal medicines and prescribed drugs: a systematic review”. Drugs. 61 (15): 2163–75. doi:10.2165/00003495-200161150-00002. PMID 11772128.
Izzo AA (martie 2004). „Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence”. International Journal of Clinical Pharmacology and Therapeutics. 42 (3): 139–48. doi:10.5414/CPP42139. PMID 15049433.
Madabushi R, Frank B, Drewelow B, Derendorf H, Butterweck V (martie 2006). „Hyperforin in St. John's wort drug interactions”. European Journal of Clinical Pharmacology. 62 (3): 225–33. doi:10.1007/s00228-006-0096-0. PMID 16477470.
Izzo AA, Ernst E (2009). „Interactions between herbal medicines and prescribed drugs: an updated systematic review”. Drugs. 69 (13): 1777–98. doi:10.2165/11317010-000000000-00000. PMID 19719333.
Welch TR, Rumack BH, Hammond K (1977). „Clonazepam overdose resulting in cyclic coma”. Clinical Toxicology. 10 (4): 433–6. doi:10.3109/15563657709046280. PMID 862377.
Seger DL (2004). „Flumazenil--treatment or toxin”. Journal of Toxicology. Clinical Toxicology. 42 (2): 209–16. doi:10.1081/CLT-120030946. PMID 15214628.
Isbister GK, O'Regan L, Sibbritt D, Whyte IM (2004). „Alprazolam is relatively more toxic than other benzodiazepines in overdose”. British Journal of Clinical Pharmacology (în engleză). 58: 88–95. doi:10.1111/j.1365-2125.2004.02089.x. PMC 1884537 . PMID 15206998.
Skelton KH, Nemeroff CB, Owens MJ (octombrie 2004). „Spontaneous withdrawal from the triazolobenzodiazepine alprazolam increases cortical corticotropin-releasing factor mRNA expression”. The Journal of Neuroscience. 24 (42): 9303–12. doi:10.1523/JNEUROSCI.1737-04.2004. PMC 6730084 . PMID 15496666.
White G, Gurley DA (februarie 1995). „Alpha subunits influence Zn block of gamma 2 containing GABAA receptor currents”. NeuroReport. 6 (3): 461–4. doi:10.1097/00001756-199502000-00014. PMID 7766843.
Arvat E, Giordano R, Grottoli S, Ghigo E (septembrie 2002). „Benzodiazepines and anterior pituitary function”. Journal of Endocrinological Investigation. 25 (8): 735–47. doi:10.1007/bf03345110. PMID 12240908.
Bentué-Ferrer D, Reymann JM, Tribut O, Allain H, Vasar E, Bourin M (februarie 2001). „Role of dopaminergic and serotonergic systems on behavioral stimulatory effects of low-dose alprazolam and lorazepam”. European Neuropsychopharmacology. 11 (1): 41–50. doi:10.1016/S0924-977X(00)00137-1. PMID 11226811.
Giardino L, Zanni M, Pozza M, Bettelli C, Covelli V (martie 1998). „Dopamine receptors in the striatum of rats exposed to repeated restraint stress and alprazolam treatment”. European Journal of Pharmacology. 344 (2–3): 143–7. doi:10.1016/s0014-2999(97)01608-7. PMID 9600648.
Walser, A, Zenchoff G (1977). „Quinazolines and 1,4-benzodiazepines. 81. s-Triazolo[4,3-a][1,4]benzodiazepines by oxidative cyclization of hydrazones”. Journal of Medicinal Chemistry. 20 (12): 1694–1697. doi:10.1021/jm00222a035.
VonVoigtlander PF, Straw RN (1985). „Alprazolam: Review of pharmacological, pharmacokinetic, and clinical data”. Drug Development Research. 6 (1): 1–12. doi:10.1002/ddr.430060102.
Hester JB, Rudzik AD, Kamdar BV (1971). „6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines which have central nervous system depressant activity”. Journal of Medicinal Chemistry. 14 (11): 1078–1081. doi:10.1021/jm00293a015.
Nakajima R, Hattori C, Nagawa Y (august 1971). „Structure-activity relationship of s-triazolo-1,4-benzodiazepines in central nervous depressant action”. The Japanese Journal of Pharmacology. 21 (4): 489–495. doi:10.1254/jjp.21.489. PMID 5315779.
Soumerai SB, Simoni-Wastila L, Singer C, Mah C, Gao X, Salzman C, Ross-Degnan D (iulie 2003). „Lack of relationship between long-term use of benzodiazepines and escalation to high dosages”. Psychiatric Services. 54 (7): 1006–11. doi:10.1176/appi.ps.54.7.1006. PMID 12851438.
Ballenger JC (decembrie 1984). „Psychopharmacology of the anxiety disorders”. The Psychiatric Clinics of North America. 7 (4): 757–71. doi:10.1016/S0193-953X(18)30728-7. PMID 6151647.
Vorma H, Naukkarinen HH, Sarna SJ, Kuoppasalmi KI (2005). „Predictors of benzodiazepine discontinuation in subjects manifesting complicated dependence”. Substance Use & Misuse. 40 (4): 499–510. doi:10.1081/JA-200052433. PMID 15830732.
Walker BM, Ettenberg A (aprilie 2003). „The effects of alprazolam on conditioned place preferences produced by intravenous heroin”. Pharmacology Biochemistry and Behavior. 75 (1): 75–80. doi:10.1016/S0091-3057(03)00043-1. PMID 12759115.
Wang EC, Chew FS (2006). „MR Findings of Alprazolam Injection into the Femoral Artery with Microembolization and Rhabdomyolysis”. Radiology Case Reports. 1 (3): 99–102. doi:10.2484/rcr.v1i3.33. PMC 4891562 . PMID 27298694.
Sheehan MF, Sheehan DV, Torres A, Coppola A, Francis E (1991). „Snorting benzodiazepines”. The American Journal of Drug and Alcohol Abuse. 17 (4): 457–68. doi:10.3109/00952999109001605. PMID 1684083.

drugabuse.com

Rai Cornell (9 februarie 2017). „Xanax Overdose”. Drug Abuse (în engleză). Accesat în 18 mai 2020.

drugbank.ca

„Alprazolam”. DrugBank - Canadian Institutes of Health Research. Accesat în februarie 2020.

drugbank.com

Alprazolam (în engleză), DrugBank, accesat în 19 noiembrie 2016
Alprazolam (în engleză), DrugBank, 17 noiembrie 2015

drugs.com

„Alprazolam Monograph for Professionals”. The American Society of Health-System Pharmacists. Accesat în 20 februarie 2020.
„Product(s) containing alprazolam”. The American Society of Health-System Pharmacists. Accesat în 12 aprilie 2020.
„Alprazolam Side Effects, Interactions and Information”. Drugs.com. Arhivat din original la 19 august 2007. Accesat în 2 august 2007.
„Alprazolam Dosage”. The American Society of Health-System Pharmacists. Accesat în februarie 2020.
„Alprazolam Oral Solution”. The American Society of Health-System Pharmacists. Accesat în februarie 2020.

e-lactancia.org

Iqbal MM, Sobhan T, Ryals T (ianuarie 2002). „Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant” (PDF). Psychiatric Services. 53 (1): 39–49. doi:10.1176/appi.ps.53.1.39. PMID 11773648.

ebi.ac.uk

alprazolam (în engleză), ChEBI, accesat în 18 octombrie 2016
ALPRAZOLAM (în engleză), ChEMBL, accesat în 19 noiembrie 2016

empr.com

„Xanax® (Alprazolam) Drug Slang/Code Words”. MPR. Accesat în 17 martie 2019.

escholarship.org

Kripke DF (februarie 2016). „Mortality Risk of Hypnotics: Strengths and Limits of Evidence” (PDF). Drug Safety. 39 (2): 93–107. doi:10.1007/s40264-015-0362-0. PMID 26563222.

fda.gov

alprazolam (în engleză), Global Substance Registration System, accesat în 19 noiembrie 2016
FDA (2017). „Both opioids and benzodiazepines depress the central nervous system (CNS). FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning”. fda.gov. ("Additional Information for Patients > bullet 5"). Accesat în 15 octombrie 2017. Do not take opioid pain medicines with benzodiazepines or other medicines that depress the CNS without discussing it with your health Do not take opioid pain medicines with benzodiazepines or other medicines that depress the CNS without discussing it with your health care professional. Do not take opioid cough medicines with benzodiazepines or other medicines that depress the CNS professional. Do not take opioid cough medicines with benzodiazepines or other medicines that depress the CNS

accessdata.fda.gov

„FDA approved labeling for Xanax revision 08/23/2011” (PDF). Federal Drug Administration. 23 august 2011. p. 4. Accesat în 20 februarie 2020.

forbes.com

„In Pictures: The Most Popular Prescription Drugs”. Forbes. Accesat în 16 iunie 2015.

gesetze-im-internet.de

„Gesetz über den Verkehr mit Betäubungsmitteln (Betäubungsmittelgesetz - BtMG) Anlage III (zu § 1 Abs. 1) (verkehrsfähige und verschreibungsfähige Betäubungsmittel)” (în germană). Bundesministerium für Justiz und Verbraucherschutz.

google.ca

books.google.ca

Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery (în engleză). John Wiley & Sons. p. 536. ISBN 9783527607495.

handle.net

hdl.handle.net

Cassano GB, Toni C, Petracca A, Deltito J, Benkert O, Curtis G, Hippius H, Maier W, Shera D, Klerman G (martie 1994). „Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo” (PDF). European Neuropsychopharmacology. 4 (1): 47–53. doi:10.1016/0924-977X(94)90314-X. hdl:2027.42/31721. PMID 8204996.
Closser MH, Brower KJ (1994). „Treatment of alprazolam withdrawal with chlordiazepoxide substitution and taper” (PDF). Journal of Substance Abuse Treatment. 11 (4): 319–23. doi:10.1016/0740-5472(94)90042-6. hdl:2027.42/31476. PMID 7966502.

incb.org

„List of Psychotropic Substances under International Control” (PDF). Incb.org. International Narcotics Control Board. august 2003. Arhivat din original (PDF) la 17 decembrie 2008. Accesat în 7 decembrie 2008.

ingentaconnect.com

Wick JY (2013). „The History of Benzodiazepines”. The Consultant Pharmacist. 28 (9): 538–548. doi:10.4140/tcp.n.2013.538.

just.ro

legislatie.just.ro

„Legea nr. 339 din 29 noiembrie 2005 privind regimul juridic al plantelor, substanțelor și preparatelor stupefiante și psihotrope”, Portal Legislativ, accesat în 20 februarie 2020

justice.gov

„DEA Brief Benzodiazepines”. Arhivat din original la 12 martie 2009. Accesat în 1 octombrie 2011. Given the millions of prescriptions written for benzodiazepines (about 100 million in 1999), relatively few individuals increase their dose on their own initiative or engage in drug-seeking behavior.
„Intelligence Alert – Xanax Blotter Paper in Bartlesville, Oklahoma” (Microgram Bulletin). US Drug Enforcement Administration. mai 2008. Arhivat din original la 21 mai 2008.

lege5.ro

„Convenția asupra substanțelor psihotrope din 21.02.1971”. Lege5. Accesat în 21 februarie 2020.

mayoclinic.org

„Side Effects”. Mayo Clinic. 1 mai 2019. Accesat în 22 mai 2019.

medicinenet.com

„Alprazolam – Oral (Xanax) Side Effects, Medical Uses, and Drug Interactions”. Medicinenet.com. MedicineNet. iulie 2005. Arhivat din original la 18 decembrie 2008. Accesat în 7 decembrie 2008.
„Alprazolam – Complete Medical Information Regarding This Treatment of Anxiety Disorders”. Medicinenet.com. MedicineNet. Accesat în 2 august 2007.

medworksmedia.com

Wang JS, DeVane CL (2003). „Pharmacokinetics and drug interactions of the sedative hypnotics” (PDF). Psychopharmacology Bulletin. 37 (1): 10–29. doi:10.1007/BF01990373. PMID 14561946. Arhivat din original (PDF) la 9 iulie 2007.

merriam-webster.com

„Definition of ALPRAZOLAM”. Merriam-webster.com. Accesat în 21 februarie 2020.

netdoctor.co.uk

„Xanax”. Netdoctor.co.uk. NetDoctor. 1 octombrie 2006. Arhivat din original la 9 august 2007. Accesat în 2 august 2007.

nih.gov

ncbi.nlm.nih.gov

Moylan S, Giorlando F, Nordfjærn T, Berk M (martie 2012). „The role of alprazolam for the treatment of panic disorder in Australia” (PDF). The Australian and New Zealand Journal of Psychiatry. 46 (3): 212–24. doi:10.1177/0004867411432074. PMID 22391278.
Dodds TJ (martie 2017). „Prescribed Benzodiazepines and Suicide Risk: A Review of the Literature”. The Primary Care Companion for CNS Disorders. 19 (2). doi:10.4088/PCC.16r02037. PMID 28257172.
Verster JC, Volkerts ER (2004). „Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature”. CNS Drug Reviews. 10 (1): 45–76. doi:10.1111/j.1527-3458.2004.tb00003.x. PMC 6741717 . PMID 14978513.
Mandrioli, R.; Mercolini, L.; Raggi, M. A. (2008). „Benzodiazepine Metabolism: An Analytical Perspective”. Current Drug Metabolism. 9 (8): 827–844. doi:10.2174/138920008786049258. PMID 18855614.
Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ (octombrie 2002). „World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders”. The World Journal of Biological Psychiatry. 3 (4): 171–99. doi:10.3109/15622970209150621. PMID 12516310.
van Marwijk H, Allick G, Wegman F, Bax A, Riphagen II (iulie 2012). van Marwijk, Harm, ed. „Alprazolam for depression” (PDF). The Cochrane Database of Systematic Reviews. 7 (7): CD007139. doi:10.1002/14651858.CD007139.pub2. PMC 6769182 . PMID 22786504. Arhivat din original (PDF) la 11 august 2017. Accesat în 20 februarie 2020.
Lydiard RB, Laraia MT, Ballenger JC, Howell EF (mai 1987). „Emergence of depressive symptoms in patients receiving alprazolam for panic disorder”. The American Journal of Psychiatry. 144 (5): 664–5. doi:10.1176/ajp.144.5.664. PMID 3578580.
Williams D, McBride AJ (1998). „The drug treatment of alcohol withdrawal symptoms: a systematic review”. Alcohol & Alcoholism. 33 (2): 103–115. doi:10.1093/oxfordjournals.alcalc.a008365. PMID 9566471.
Tsavaris N, Tsoutsos H, Bacoyannis C, Mylonakis N, Karvounis N, Kozatsani-Halividi D, Tsaroucha-Noutsou E, Klinaki A, Kosmidis P (1991). „Antiemetic efficacy of alprazolam in carboplatin-induced emesis”. Chemotherapy. 37 (5): 364–70. doi:10.1159/000238880. PMID 1804597.
Authier N, Balayssac D, Sautereau M, Zangarelli A, Courty P, Somogyi AA, Vennat B, Llorca PM, Eschalier A (noiembrie 2009). „Benzodiazepine dependence: focus on withdrawal syndrome”. Annales Pharmaceutiques Francaises. 67 (6): 408–13. doi:10.1016/j.pharma.2009.07.001. PMID 19900604.
Hori A (februarie 1998). „Pharmacotherapy for personality disorders”. Psychiatry and Clinical Neurosciences. 52 (1): 13–9. doi:10.1111/j.1440-1819.1998.tb00967.x. PMID 9682928.
Gardner DL, Cowdry RW (ianuarie 1985). „Alprazolam-induced dyscontrol in borderline personality disorder”. The American Journal of Psychiatry. 142 (1): 98–100. doi:10.1176/ajp.142.1.98. PMID 2857071.
Kozená L, Frantik E, Horváth M (mai 1995). „Vigilance impairment after a single dose of benzodiazepines”. Psychopharmacology. 119 (1): 39–45. doi:10.1007/BF02246052. PMID 7675948.
Cassano GB, Toni C, Petracca A, Deltito J, Benkert O, Curtis G, Hippius H, Maier W, Shera D, Klerman G (martie 1994). „Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo” (PDF). European Neuropsychopharmacology. 4 (1): 47–53. doi:10.1016/0924-977X(94)90314-X. hdl:2027.42/31721. PMID 8204996.
Elie R, Lamontagne Y (iunie 1984). „Alprazolam and diazepam in the treatment of generalized anxiety”. Journal of Clinical Psychopharmacology. 4 (3): 125–9. doi:10.1097/00004714-198406000-00002. PMID 6145726.
Rawson NS, Rawson MJ (1999). „Acute adverse event signalling scheme using the Saskatchewan Administrative health care utilization datafiles: results for two benzodiazepines”. Canadian Journal of Clinical Pharmacology. 6 (3): 159–66. PMID 10495368.
Barbee JG (octombrie 1993). „Memory, benzodiazepines, and anxiety: integration of theoretical and clinical perspectives”. The Journal of Clinical Psychiatry. 54 Suppl (Suppl): 86–97; discussion 98–101. PMID 8262893.
Michel L, Lang JP (2003). „[Benzodiazepines and forensic aspects]” [Benzodiazepines and Forensic Aspects]. L'Encephale (în franceză). 29 (6): 479–85. PMID 15029082.
Noyes R, DuPont RL, Pecknold JC, Rifkin A, Rubin RT, Swinson RP, Ballenger JC, Burrows GD (mai 1988). „Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety”. Archives of General Psychiatry. 45 (5): 423–8. doi:10.1001/archpsyc.1988.01800290037005. PMID 3358644.
Kripke DF (februarie 2016). „Mortality Risk of Hypnotics: Strengths and Limits of Evidence” (PDF). Drug Safety. 39 (2): 93–107. doi:10.1007/s40264-015-0362-0. PMID 26563222.
Patorno E, Glynn RJ, Levin R, Lee MP, Huybrechts KF (2017). „Benzodiazepines and risk of all cause mortality in adults: cohort study”. BMJ (în engleză). 358 (j2941). doi:10.1136/bmj.j2941. PMC 5499256 . PMID 28684397.
Rapaport M, Braff DL (ianuarie 1985). „Alprazolam and hostility”. The American Journal of Psychiatry. 142 (1): 146a–146. doi:10.1176/ajp.142.1.146a. PMID 2857070.
Arana GW, Pearlman C, Shader RI (martie 1985). „Alprazolam-induced mania: two clinical cases”. The American Journal of Psychiatry. 142 (3): 368–9. doi:10.1176/ajp.142.3.368. PMID 2857534.
Strahan A, Rosenthal J, Kaswan M, Winston A (iulie 1985). „Three case reports of acute paroxysmal excitement associated with alprazolam treatment”. The American Journal of Psychiatry. 142 (7): 859–61. CiteSeerX 10.1.1.461.6316 . doi:10.1176/ajp.142.7.859. PMID 2861755.
Reddy J, Khanna S, Anand U, Banerjee A (august 1996). „Alprazolam-induced hypomania”. The Australian and New Zealand Journal of Psychiatry. 30 (4): 550–2. CiteSeerX 10.1.1.941.5119 . doi:10.3109/00048679609065031. PMID 8887708.
Béchir M, Schwegler K, Chenevard R, Binggeli C, Caduff C, Büchi S, Buddeberg C, Lüscher TF, Noll G (iulie 2007). „Anxiolytic therapy with alprazolam increases muscle sympathetic activity in patients with panic disorders”. Autonomic Neuroscience. 134 (1–2): 69–73. doi:10.1016/j.autneu.2007.01.007. PMID 17363337.
Oo CY, Kuhn RJ, Desai N, Wright CE, McNamara PJ (septembrie 1995). „Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk”. British Journal of Clinical Pharmacology. 40 (3): 231–6. doi:10.1111/j.1365-2125.1995.tb05778.x. PMC 1365102 . PMID 8527284.
Iqbal MM, Sobhan T, Ryals T (ianuarie 2002). „Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant” (PDF). Psychiatric Services. 53 (1): 39–49. doi:10.1176/appi.ps.53.1.39. PMID 11773648.
García-Algar O, López-Vílchez MA, Martín I, Mur A, Pellegrini M, Pacifici R, Rossi S, Pichini S (2007). „Confirmation of gestational exposure to alprazolam by analysis of biological matrices in a newborn with neonatal sepsis”. Clinical Toxicology. 45 (3): 295–8. doi:10.1080/15563650601072191. PMID 17453885.
Einarson A, Selby P, Koren G (ianuarie 2001). „Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling”. Journal of Psychiatry & Neuroscience. 26 (1): 44–8. PMC 1408034 . PMID 11212593.
Isbister GK, O'Regan L, Sibbritt D, Whyte IM (iulie 2004). „Alprazolam is relatively more toxic than other benzodiazepines in overdose”. British Journal of Clinical Pharmacology. 58 (1): 88–95. doi:10.1111/j.1365-2125.2004.02089.x. PMC 1884537 . PMID 15206998.
An H, Godwin J (decembrie 2016). „Flumazenil in benzodiazepine overdose”. British Journal of Clinical Pharmacology. 188 (17-18): E537. doi:10.1503/cmaj.160357. PMC 5135539 . PMID 27920113.
Juergens SM, Morse RM (mai 1988). „Alprazolam dependence in seven patients”. The American Journal of Psychiatry. 145 (5): 625–7. doi:10.1176/ajp.145.5.625. PMID 3258735.
Klein E (2002). „The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam”. The Journal of Clinical Psychiatry. 63 Suppl 14 (Suppl 14): 27–33. PMID 12562116.
Closser MH, Brower KJ (1994). „Treatment of alprazolam withdrawal with chlordiazepoxide substitution and taper” (PDF). Journal of Substance Abuse Treatment. 11 (4): 319–23. doi:10.1016/0740-5472(94)90042-6. hdl:2027.42/31476. PMID 7966502.
Fyer AJ, Liebowitz MR, Gorman JM, Campeas R, Levin A, Davies SO, Goetz D, Klein DF (martie 1987). „Discontinuation of alprazolam treatment in panic patients”. The American Journal of Psychiatry. 144 (3): 303–8. doi:10.1176/ajp.144.3.303. PMID 3826428.
Breier A, Charney DS, Nelson JC (decembrie 1984). „Seizures induced by abrupt discontinuation of alprazolam”. The American Journal of Psychiatry. 141 (12): 1606–7. doi:10.1176/ajp.141.12.1606. PMID 6150649.
Noyes R, Perry PJ, Crowe RR, Coryell WH, Clancy J, Yamada T, Gabel J (ianuarie 1986). „Seizures following the withdrawal of alprazolam”. The Journal of Nervous and Mental Disease. 174 (1): 50–2. doi:10.1097/00005053-198601000-00009. PMID 2867122.
Levy AB (ianuarie 1984). „Delirium and seizures due to abrupt alprazolam withdrawal: case report”. The Journal of Clinical Psychiatry. 45 (1): 38–9. PMID 6141159.
Wolf B, Griffiths RR (decembrie 1991). „Physical dependence on benzodiazepines: differences within the class”. Drug and Alcohol Dependence. 29 (2): 153–6. doi:10.1016/0376-8716(91)90044-Y. PMID 1686752.
Higgitt A, Fonagy P, Lader M (1988). „The natural history of tolerance to the benzodiazepines”. Psychological Medicine. Monograph Supplement. 13: 1–55. doi:10.1017/S0264180100000412. PMID 2908516.
Otani K (2003). „[Cytochrome P450 3A4 and Benzodiazepines]”. Seishin Shinkeigaku Zasshi = Psychiatria et Neurologia Japonica (în japoneză). 105 (5): 631–42. PMID 12875231.
Greenblatt DJ, von Moltke LL, Harmatz JS, Durol AL, Daily JP, Graf JA, Mertzanis P, Hoffman JL, Shader RI (aprilie 2000). „Alprazolam-ritonavir interaction: implications for product labeling”. Clin Pharmacol Ther. 67 (4): 335–41. doi:10.1067/mcp.2000.105757. PMID 10801241.
Dresser GK, Spence JD, Bailey DG (ianuarie 2000). „Pharmacokinetic-pharmacodymic consequences and clinical relevance of cytochrome P450 3A4 inhibition”. Clinical Pharmacokinetics. 38 (1): 41–57. doi:10.2165/00003088-200038010-00003. PMID 10668858.
Greenblatt DJ, Wright CE (iunie 1993). „Clinical pharmacokinetics of alprazolam. Therapeutic implications”. Clinical Pharmacokinetics. 24 (6): 453–71. doi:10.2165/00003088-199324060-00003. PMID 8513649.
Wang JS, DeVane CL (2003). „Pharmacokinetics and drug interactions of the sedative hypnotics” (PDF). Psychopharmacology Bulletin. 37 (1): 10–29. doi:10.1007/BF01990373. PMID 14561946. Arhivat din original (PDF) la 9 iulie 2007.
Back DJ, Orme ML (iunie 1990). „Pharmacokinetic drug interactions with oral contraceptives”. Clinical Pharmacokinetics. 18 (6): 472–84. doi:10.2165/00003088-199018060-00004. PMID 2191822.
Almeida JC, Grimsley EW (1996). „Coma from the health food store: interaction between kava and alprazolam”. Annals of Internal Medicine. 125 (11): 940–1. doi:10.7326/0003-4819-125-11-199612010-00023. PMID 8967683.
Izzo AA, Ernst E (2001). „Interactions between herbal medicines and prescribed drugs: a systematic review”. Drugs. 61 (15): 2163–75. doi:10.2165/00003495-200161150-00002. PMID 11772128.
Izzo AA (martie 2004). „Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence”. International Journal of Clinical Pharmacology and Therapeutics. 42 (3): 139–48. doi:10.5414/CPP42139. PMID 15049433.
Madabushi R, Frank B, Drewelow B, Derendorf H, Butterweck V (martie 2006). „Hyperforin in St. John's wort drug interactions”. European Journal of Clinical Pharmacology. 62 (3): 225–33. doi:10.1007/s00228-006-0096-0. PMID 16477470.
Izzo AA, Ernst E (2009). „Interactions between herbal medicines and prescribed drugs: an updated systematic review”. Drugs. 69 (13): 1777–98. doi:10.2165/11317010-000000000-00000. PMID 19719333.
Welch TR, Rumack BH, Hammond K (1977). „Clonazepam overdose resulting in cyclic coma”. Clinical Toxicology. 10 (4): 433–6. doi:10.3109/15563657709046280. PMID 862377.
el-Khordagui LK, Saleh AM, KhalIl SA (1987). „Adsorption of benzodiazepines on charcoal and its correlation with in vitro and in vivo data”. Pharmaceutica Acta Helvetiae. 62 (1): 28–32. PMID 2882522.
Seger DL (2004). „Flumazenil--treatment or toxin”. Journal of Toxicology. Clinical Toxicology. 42 (2): 209–16. doi:10.1081/CLT-120030946. PMID 15214628.
Isbister GK, O'Regan L, Sibbritt D, Whyte IM (2004). „Alprazolam is relatively more toxic than other benzodiazepines in overdose”. British Journal of Clinical Pharmacology (în engleză). 58: 88–95. doi:10.1111/j.1365-2125.2004.02089.x. PMC 1884537 . PMID 15206998.
Huybrechts, I (1991). „The pharmacology of alprazolam: a review”. Clinical Therapeutics. 13 (1): 100–17. PMID 2029716.
Skelton KH, Nemeroff CB, Owens MJ (octombrie 2004). „Spontaneous withdrawal from the triazolobenzodiazepine alprazolam increases cortical corticotropin-releasing factor mRNA expression”. The Journal of Neuroscience. 24 (42): 9303–12. doi:10.1523/JNEUROSCI.1737-04.2004. PMC 6730084 . PMID 15496666.
Chouinard G (2004). „Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound”. The Journal of Clinical Psychiatry. 65 Suppl 5 (Suppl 5): 7–12. PMID 15078112.
Huybrechts, I. (ianuarie 1991). „The pharmacology of alprazolam: a review”. Clinical Therapeutics. 13 (1): 100–117. ISSN 0149-2918. PMID 2029716.
White G, Gurley DA (februarie 1995). „Alpha subunits influence Zn block of gamma 2 containing GABAA receptor currents”. NeuroReport. 6 (3): 461–4. doi:10.1097/00001756-199502000-00014. PMID 7766843.
Arvat E, Giordano R, Grottoli S, Ghigo E (septembrie 2002). „Benzodiazepines and anterior pituitary function”. Journal of Endocrinological Investigation. 25 (8): 735–47. doi:10.1007/bf03345110. PMID 12240908.
Bentué-Ferrer D, Reymann JM, Tribut O, Allain H, Vasar E, Bourin M (februarie 2001). „Role of dopaminergic and serotonergic systems on behavioral stimulatory effects of low-dose alprazolam and lorazepam”. European Neuropsychopharmacology. 11 (1): 41–50. doi:10.1016/S0924-977X(00)00137-1. PMID 11226811.
Giardino L, Zanni M, Pozza M, Bettelli C, Covelli V (martie 1998). „Dopamine receptors in the striatum of rats exposed to repeated restraint stress and alprazolam treatment”. European Journal of Pharmacology. 344 (2–3): 143–7. doi:10.1016/s0014-2999(97)01608-7. PMID 9600648.
Nakajima R, Hattori C, Nagawa Y (august 1971). „Structure-activity relationship of s-triazolo-1,4-benzodiazepines in central nervous depressant action”. The Japanese Journal of Pharmacology. 21 (4): 489–495. doi:10.1254/jjp.21.489. PMID 5315779.
Soumerai SB, Simoni-Wastila L, Singer C, Mah C, Gao X, Salzman C, Ross-Degnan D (iulie 2003). „Lack of relationship between long-term use of benzodiazepines and escalation to high dosages”. Psychiatric Services. 54 (7): 1006–11. doi:10.1176/appi.ps.54.7.1006. PMID 12851438.
Ballenger JC (decembrie 1984). „Psychopharmacology of the anxiety disorders”. The Psychiatric Clinics of North America. 7 (4): 757–71. doi:10.1016/S0193-953X(18)30728-7. PMID 6151647.
Ciraulo DA, Barnhill JG, Greenblatt DJ, Shader RI, Ciraulo AM, Tarmey MF, Molloy MA, Foti ME (septembrie 1988). „Abuse liability and clinical pharmacokinetics of alprazolam in alcoholic men”. The Journal of Clinical Psychiatry. 49 (9): 333–7. PMID 3417618.
Vorma H, Naukkarinen HH, Sarna SJ, Kuoppasalmi KI (2005). „Predictors of benzodiazepine discontinuation in subjects manifesting complicated dependence”. Substance Use & Misuse. 40 (4): 499–510. doi:10.1081/JA-200052433. PMID 15830732.
Walker BM, Ettenberg A (aprilie 2003). „The effects of alprazolam on conditioned place preferences produced by intravenous heroin”. Pharmacology Biochemistry and Behavior. 75 (1): 75–80. doi:10.1016/S0091-3057(03)00043-1. PMID 12759115.
Wang EC, Chew FS (2006). „MR Findings of Alprazolam Injection into the Femoral Artery with Microembolization and Rhabdomyolysis”. Radiology Case Reports. 1 (3): 99–102. doi:10.2484/rcr.v1i3.33. PMC 4891562 . PMID 27298694.
Sheehan MF, Sheehan DV, Torres A, Coppola A, Francis E (1991). „Snorting benzodiazepines”. The American Journal of Drug and Alcohol Abuse. 17 (4): 457–68. doi:10.3109/00952999109001605. PMID 1684083.

pubchem.ncbi.nlm.nih.gov

„Alprazolam”, alprazolam (în engleză), PubChem, accesat în 19 noiembrie 2016
„Alprazolam”, alprazolam (în engleză), PubChem, accesat în 18 octombrie 2016

non-benzodiazepines.org.uk

„Benzodiazepine Names”. Non-benzodiazepines.org.uk. Arhivat din original la 8 decembrie 2008. Accesat în 31 octombrie 2008.

nytimes.com

Goodnough, Abby (14 septembrie 2011). „Abuse of Xanax Leads a Clinic to Halt Supply”. New York Times. The Centers for Disease Control and Prevention last year reported an 89 percent increase in emergency room visits nationwide related to nonmedical benzodiazepine use between 2004 and 2008.

patents.google.com

Jackson Jun Hester. „Patent US3709898A - Process for the production of triazolobenzodiazepines and intermediates”. Google Patents. Accesat în 21 februarie 2020.
Jackson B. Hester, Jr., Patent US3987052A - 6-Phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepines, Google Patents, accesat în 21 februarie 2020
Jackson Boling Jun Hester. „Patent DE2012190A1- new benzodiazepine derivatives”. Google Patents. Accesat în 21 februarie 2020.

psu.edu

citeseerx.ist.psu.edu

Strahan A, Rosenthal J, Kaswan M, Winston A (iulie 1985). „Three case reports of acute paroxysmal excitement associated with alprazolam treatment”. The American Journal of Psychiatry. 142 (7): 859–61. CiteSeerX 10.1.1.461.6316 . doi:10.1176/ajp.142.7.859. PMID 2861755.
Reddy J, Khanna S, Anand U, Banerjee A (august 1996). „Alprazolam-induced hypomania”. The Australian and New Zealand Journal of Psychiatry. 30 (4): 550–2. CiteSeerX 10.1.1.941.5119 . doi:10.3109/00048679609065031. PMID 8887708.

psychiatrist.com

Klein E (2002). „The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam”. The Journal of Clinical Psychiatry. 63 Suppl 14 (Suppl 14): 27–33. PMID 12562116.
Chouinard G (2004). „Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound”. The Journal of Clinical Psychiatry. 65 Suppl 5 (Suppl 5): 7–12. PMID 15078112.

psychiatryonline.org

Work Group on Panic Disorder (ianuarie 2009). APA Practice Guideline for the Treatment of Patients With Panic Disorder (PDF). 1 (ed. 2nd). doi:10.1176/appi.books.9780890423905.154688. ISBN 978-0-89042-385-1.

researchgate.net

Michel L, Lang JP (2003). „[Benzodiazepines and forensic aspects]” [Benzodiazepines and Forensic Aspects]. L'Encephale (în franceză). 29 (6): 479–85. PMID 15029082.
Béchir M, Schwegler K, Chenevard R, Binggeli C, Caduff C, Büchi S, Buddeberg C, Lüscher TF, Noll G (iulie 2007). „Anxiolytic therapy with alprazolam increases muscle sympathetic activity in patients with panic disorders”. Autonomic Neuroscience. 134 (1–2): 69–73. doi:10.1016/j.autneu.2007.01.007. PMID 17363337.
Izzo AA, Ernst E (2001). „Interactions between herbal medicines and prescribed drugs: a systematic review”. Drugs. 61 (15): 2163–75. doi:10.2165/00003495-200161150-00002. PMID 11772128.

rhrn.ro

Xanax/Alprazolam - Utilizare în regim de drog, Romanian Harm Reduction Network, accesat în 21 februarie 2020

rxlist.com

„Xanax (Alprazolam)”. RxList. 20 februarie 2020.
„Xanax (Alprazolam) Drug Information: Uses, Side Effects, Drug Interactions and Warnings”. RxList. iulie 2008. p. 8. Arhivat din original la 13 septembrie 2008. Accesat în 7 decembrie 2008.

rxwiki.com

„Alprazolam Dosage, Uses, Overdose Info and More”. RXwiki.com. 18 noiembrie 2013. Accesat în 22 ianuarie 2014.

samhsa.gov

„Drug Abuse Warning Network, 2006: National Estimates of Drug-Related Emergency Department Visits” (PDF). U.S. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. 2006. Arhivat din original (PDF) la 12 martie 2012. Accesat în 13 februarie 2012.

state.oh.us

odadas.state.oh.us

„OSAM-O-GRAM Highlights of Statewide Drug Use Trends” (PDF). Ohio, US: Wright State University and the University of Akron. ianuarie 2008. Arhivat din original (PDF) la 7 august 2011. Accesat în 10 decembrie 2008.

statutelaw.gov.uk

„Misuse of Drugs Act 1971 (c. 38)”. The UK Statute Law database. 1991.

thedrugclassroom.com

„Alprazolam”. The Drug Classroom. Arhivat din original la 22 ianuarie 2019. Accesat în 21 februarie 2020.

therecoveryvillage.com

„Who Discovered Xanax?”, The Recovery Village, 5 iunie 2017, accesat în 12 aprilie 2020

ualberta.ca

redpoll.pharmacy.ualberta.ca

„DB00404 (Alprazolam)”. Canada: DrugBank. 26 iunie 2008. Arhivat din original la 29 ianuarie 2008. Accesat în 12 iulie 2011.

umich.edu

deepblue.lib.umich.edu

Cassano GB, Toni C, Petracca A, Deltito J, Benkert O, Curtis G, Hippius H, Maier W, Shera D, Klerman G (martie 1994). „Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo” (PDF). European Neuropsychopharmacology. 4 (1): 47–53. doi:10.1016/0924-977X(94)90314-X. hdl:2027.42/31721. PMID 8204996.
Closser MH, Brower KJ (1994). „Treatment of alprazolam withdrawal with chlordiazepoxide substitution and taper” (PDF). Journal of Substance Abuse Treatment. 11 (4): 319–23. doi:10.1016/0740-5472(94)90042-6. hdl:2027.42/31476. PMID 7966502.

usdoj.gov

„DEA, Drug Scheduling”. DEA. Arhivat din original la 4 noiembrie 2008. Accesat în 31 octombrie 2008.

vu.nl

dare.ubvu.vu.nl

van Marwijk H, Allick G, Wegman F, Bax A, Riphagen II (iulie 2012). van Marwijk, Harm, ed. „Alprazolam for depression” (PDF). The Cochrane Database of Systematic Reviews. 7 (7): CD007139. doi:10.1002/14651858.CD007139.pub2. PMC 6769182 . PMID 22786504. Arhivat din original (PDF) la 11 august 2017. Accesat în 20 februarie 2020.

web.archive.org

van Marwijk H, Allick G, Wegman F, Bax A, Riphagen II (iulie 2012). van Marwijk, Harm, ed. „Alprazolam for depression” (PDF). The Cochrane Database of Systematic Reviews. 7 (7): CD007139. doi:10.1002/14651858.CD007139.pub2. PMC 6769182 . PMID 22786504. Arhivat din original (PDF) la 11 august 2017. Accesat în 20 februarie 2020.
„Xanax”. Netdoctor.co.uk. NetDoctor. 1 octombrie 2006. Arhivat din original la 9 august 2007. Accesat în 2 august 2007.
„Alprazolam – Oral (Xanax) Side Effects, Medical Uses, and Drug Interactions”. Medicinenet.com. MedicineNet. iulie 2005. Arhivat din original la 18 decembrie 2008. Accesat în 7 decembrie 2008.
„Alprazolam Side Effects, Interactions and Information”. Drugs.com. Arhivat din original la 19 august 2007. Accesat în 2 august 2007.
„Xanax (Alprazolam) Drug Information: Uses, Side Effects, Drug Interactions and Warnings”. RxList. iulie 2008. p. 8. Arhivat din original la 13 septembrie 2008. Accesat în 7 decembrie 2008.
„DEA Brief Benzodiazepines”. Arhivat din original la 12 martie 2009. Accesat în 1 octombrie 2011. Given the millions of prescriptions written for benzodiazepines (about 100 million in 1999), relatively few individuals increase their dose on their own initiative or engage in drug-seeking behavior.
„Rezumatul caracteristicilor produsului - Frontin 1 mg comprimate” (PDF). Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România. Arhivat din original (PDF) la 21 februarie 2020. Accesat în februarie 2020.
Wang JS, DeVane CL (2003). „Pharmacokinetics and drug interactions of the sedative hypnotics” (PDF). Psychopharmacology Bulletin. 37 (1): 10–29. doi:10.1007/BF01990373. PMID 14561946. Arhivat din original (PDF) la 9 iulie 2007.
„Alprazolam”. The Drug Classroom. Arhivat din original la 22 ianuarie 2019. Accesat în 21 februarie 2020.
„Benzodiazepine Names”. Non-benzodiazepines.org.uk. Arhivat din original la 8 decembrie 2008. Accesat în 31 octombrie 2008.
„Drug Abuse Warning Network, 2006: National Estimates of Drug-Related Emergency Department Visits” (PDF). U.S. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. 2006. Arhivat din original (PDF) la 12 martie 2012. Accesat în 13 februarie 2012.
„OSAM-O-GRAM Highlights of Statewide Drug Use Trends” (PDF). Ohio, US: Wright State University and the University of Akron. ianuarie 2008. Arhivat din original (PDF) la 7 august 2011. Accesat în 10 decembrie 2008.
„DB00404 (Alprazolam)”. Canada: DrugBank. 26 iunie 2008. Arhivat din original la 29 ianuarie 2008. Accesat în 12 iulie 2011.
„Intelligence Alert – Xanax Blotter Paper in Bartlesville, Oklahoma” (Microgram Bulletin). US Drug Enforcement Administration. mai 2008. Arhivat din original la 21 mai 2008.
„Street Terms for Xanax”. Axisresidentialtreatment.com. Arhivat din original la 22 februarie 2014. Accesat în 14 februarie 2014.
„Street Names for Alprazolam”. Alprazolamaddictionhelp.com. Arhivat din original la 22 februarie 2014. Accesat în 14 februarie 2014.
„Regimul juridic al plantelor, substanțelor și preparatelor stupefiante și psihotrope”. Casa Județeană de Asigurări de Sănătate Maramureș. Arhivat din original la 21 februarie 2020. Accesat în 21 februarie 2020.
„DEA, Drug Scheduling”. DEA. Arhivat din original la 4 noiembrie 2008. Accesat în 31 octombrie 2008.
„List of Psychotropic Substances under International Control” (PDF). Incb.org. International Narcotics Control Board. august 2003. Arhivat din original (PDF) la 17 decembrie 2008. Accesat în 7 decembrie 2008.

wiley.com

onlinelibrary.wiley.com

VonVoigtlander PF, Straw RN (1985). „Alprazolam: Review of pharmacological, pharmacokinetic, and clinical data”. Drug Development Research. 6 (1): 1–12. doi:10.1002/ddr.430060102.

worldcat.org

Andrew, Hitchings (2014). Top 100 drugs : clinical pharmacology and practical prescribing. Lonsdale, Dagan,, Burrage, Daniel,, Baker, Emma. Edinburgh. ISBN 9780702055164. OCLC 864676781.
Huybrechts, I. (ianuarie 1991). „The pharmacology of alprazolam: a review”. Clinical Therapeutics. 13 (1): 100–117. ISSN 0149-2918. PMID 2029716.